Orpea SA (EMEIS) AI Stock Analysis

• Market Cap: €1.94B
• Dividend Yield: N/A
• Average Volume (3M): 298.19K
• Price to Earnings (P/E): <0.1
• Beta (1Y): 4.40
• Revenue Growth: 8.43%
• EPS Growth: -102.06%
• Country: FR
• Employees: 51,071
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): -0.96
• Shares Outstanding: 161,440,050
• 10 Day Avg. Volume: 302,355
• 30 Day Avg. Volume: 298,190
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €9.00
• Price Target Upside: -24.11% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 40 Neutral
• Price Target: €11.00 ▼(-7.25% Downside)

Orpea SA's overall stock score is primarily impacted by its weak financial performance, characterized by high leverage and negative profitability. Technical analysis indicates bearish momentum, while valuation metrics are unattractive due to negative earnings. The lack of earnings call data and corporate events further limits positive influences on the score.

Orpea SA Business Overview & Revenue Model

Company Description

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.

How the Company Makes Money

Orpea SA primarily generates revenue through the provision of care services in its nursing homes and rehabilitation facilities. Key revenue streams include government reimbursements, private payments from residents, and health insurance reimbursements. The company benefits from partnerships with local governments and health authorities, which provide funding and subsidies for care services. Additionally, Orpea may earn income from ancillary services such as physiotherapy, occupational therapy, and other specialized medical services offered to residents. The company's strategic expansion into new markets and continuous investment in facility enhancements also contribute to its overall earnings.

Orpea SA Financial Statement Overview

Summary

Orpea SA's financial performance is concerning with negative EBIT and net income indicating operational challenges. High debt levels and negative stockholder equity further highlight financial distress, despite positive operating cash flow.

Income Statement

Orpea SA's revenue has shown a steady growth trend with a notable increase from 2020 to 2024. However, profitability metrics are concerning. Both EBIT and Net Income are negative in 2024, indicating operational challenges and lack of profitability. The gross profit margin has improved significantly from previous years, suggesting some operational efficiency gains, but the overall financial health is undermined by persistent losses.

Balance Sheet

The company has a high debt-to-equity ratio due to substantial total debt which has remained high over the years. While the equity ratio is low, indicating high leverage, the company's stockholder equity has been declining, posing a risk to financial stability. Negative stockholders' equity in recent years highlights financial distress.

Cash Flow

Orpea SA has managed to maintain positive operating cash flow, which is a positive sign of cash-generating capability. The free cash flow has shown growth, but the free cash flow to net income ratio indicates challenges, as net income remains negative. The operating cash flow to net income ratio is strong due to the negative net income, which reflects operational cash flow resilience despite profitability issues.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.64B	5.20B	4.68B	4.30B	3.92B
Gross Profit	4.51B	655.93M	713.73M	922.68M	963.25M
EBITDA	731.55M	2.80B	-3.45B	646.07M	637.64M
Net Income	-412.06M	1.35B	-4.03B	65.19M	160.05M
Balance Sheet
Total Assets	13.41B	13.91B	14.49B	17.07B	16.97B
Cash, Cash Equivalents and Short-Term Investments	518.72M	692.95M	902.99M	957.70M	894.13M
Total Debt	8.86B	9.16B	13.38B	12.25B	10.51B
Total Liabilities	11.69B	12.02B	16.00B	14.74B	13.48B
Stockholders Equity	1.72B	1.89B	-1.50B	2.32B	3.50B
Cash Flow
Free Cash Flow	328.61M	216.90M	244.74M	331.85M	283.29M
Operating Cash Flow	472.05M	366.14M	409.73M	753.75M	777.73M
Investing Cash Flow	-140.43M	-318.17M	-657.49M	-1.41B	-1.01B
Financing Cash Flow	-458.08M	-259.44M	151.81M	718.30M	285.80M

Orpea SA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 11.86
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:EMEIS, the sentiment is Positive. The current price of 11.86 is below the 20-day moving average (MA) of 12.33, below the 50-day MA of 12.34, and above the 200-day MA of 9.98, indicating a neutral trend. The MACD of -0.28 indicates Negative momentum. The RSI at 48.54 is Neutral, neither overbought nor oversold. The STOCH value of 78.92 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:EMEIS.

Orpea SA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
LNA	70 Outperform	301.14M	13.55	6.95%	4.50%	9.58%	-6.69%
CLARI	58 Neutral	1.50B	-32.36	-1.49%	―	1.98%	85.87%
GDS	48 Neutral	1.09B	-20.16	-4.72%	―	4.70%	-0.33%
EMEIS	40 Neutral	€1.94B	0.02	-22.82%	―	8.43%	-102.06%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%